(1)
FREMONT, Calif., March 16, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the Global Rare Disease Diagnostics Market
highlights that the market is projected to reach $70.69 billion by 2030. The study also highlights that the market is set to witness a CAGR of 8.57% during the forecast period, 2020 and 2030, aided primarily by the impressive growth in the underlying services market.
The comprehensive study covers the following:
Market numbers on micro-segments that are influencing the market?
More than 200 products present in the market
Market share analysis for more than 15 companies and study of data of more than 30 companies
End user preference data for over 20 end-users
Global Cell and Gene Therapy Market to Reach $25 00 Billion by 2027, Reports BIS Research
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
FREMONT, Calif., Feb. 23, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the title Global Single-Cell Multi-Omics Market highlights that the market is projected to reach $3.18 billion by 2025. The study also highlights that the market is set to witness a CAGR of 21.16% during the period between 2020 and 2025. The growth is aided by factors including increasing utilization of single-cell RNA sequencing for various cancer research.
The single-cell multi-omics approach enables integrating different molecules and analyzing different types of molecules from a same cell. This helps in accessing multi-faceted information and insights on the characteristics of molecular layers of several individual cells. The information derived is further beneficial in diagnosing and modifying the drugs being developed. Through the advances in single-cell analysis assays, information on the genotypic and phenotypic traits c
The 400-odd footpath vendors of Sakchi market have finally been shifted to a new address from Tuesday - the sprawling Aambagan ground.
The popular
Mangala Haat , organised every Tuesday inside the market has been shifted to the new venue too. All footpath vendors have agreed to transact business from the new venue. We, therefore decked up the ground with colourful balloons on Tuesday to attract customers, said Md. Shamim, a footwear vendor who has been running a makeshift shop inside the Sakchi market for the last 12 years.
Another garment vendor Arun Kumar said, We are happy to shift to the new venue though many customers are not aware of the change. Gradually, they will come to know and we hope it will be business as usual in the days to come.
Share this article
Share this article
FREMONT, Calif., Jan. 13, 2021 /PRNewswire/ The premium market intelligence report published by BIS Research on the title Global MRD Testing Market highlights that the market is projected to reach $1.61 billion by 2025. The study also highlights that the market is set to witness a CAGR of 15.64% during the period between 2020 and 2025. The growth is aided by factors including increasing research funding from the National Cancer Institute and rising incidence of hematologic malignancies, among others.
Minimal residual disease (MRD) testing is an evolving testing regimen that has been driving initiatives in the management of hematological malignancy patients. It is currently one of the fastest-growing markets under the molecular diagnostics umbrella. MRD testing promises the integration of evolutionary molecular technologies into hematological malignancy care regimens, thereby driving tremendous growth in the overall hematological malignanc
vimarsana © 2020. All Rights Reserved.